Company profile
American Green, Inc.
OTC: ERBB · Healthcare · Drug Manufacturers - Specialty & Generic
#834 of 1,418 Healthcare companies by revenue31st-percentile growth
EA Score
51DFH 56DQ —GM 38SS 51
v0.1 · 45/100 weight · provisional
↑ return on assets, net margin · ↓ balance-sheet leverage, Altman-Z
Methodology →Revenue TTM
$1.5M
Rev growth YoY (TTM)
-59.0%
Net income (FY)
$9.6M
Employees
12
as of 2026-08-27
Market cap
$1.1M
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.5M$1.5M2024
Net income$9.6M$9.6M2024
Operating income-$66.8k-$66.8k2024
Total assets$352.7k$352.7k2024
Liabilities$10.7M$10.7M2024
Equity-$10.3M-$10.3M2024
Revenue trend
FY2017 – FY2024 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is American Green, Inc.’s revenue?
American Green, Inc. booked $1.5M in FY2024 revenue, contracting 13% year over year — slower than 69% of Healthcare companies we track, at a 658.8% net margin.
Peers · Healthcare
Statera Biopharma, Inc.——Xsovt Brands, Inc.——Glow Lifetech Corp.——Daxor Corporation——Perspective Therapeutics, Inc.46DBraxia Scientific Corp.——Neighbors
Sheridan →Key facts
CEODavid G. Gwyther
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersSheridan, WY
ExchangeOTC: ERBB
Employees12
IPO date1996-08-27
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.